Dr Herman J Cestero Jr, MD | |
Cond Plaza Del Mar, 3001 Ave Isla Verde Apt 2004, Carolina, PR 00979-4905 | |
(787) 550-4940 | |
Not Available |
Full Name | Dr Herman J Cestero Jr |
---|---|
Gender | Male |
Speciality | Plastic Surgery |
Location | Cond Plaza Del Mar, Carolina, Puerto Rico |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1336318096 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208200000X | Plastic Surgery | 003386 (Puerto Rico) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Herman J Cestero Jr, MD 251 Calle Chile, San Juan, PR 00917-2104 Ph: (787) 550-4940 | Dr Herman J Cestero Jr, MD Cond Plaza Del Mar, 3001 Ave Isla Verde Apt 2004, Carolina, PR 00979-4905 Ph: (787) 550-4940 |
News Archive
The Institute for Aging Research of Hebrew SeniorLife, an affiliate of Harvard Medical School, today announced that Dr. Lisa Samelson and the Institute were awarded a $2.7 million grant from the National Institute on Aging to conduct a five-year study to better understand the cause of hyperkyphosis, a condition that causes extreme forward curvature of the spine.
Prior treatment with inhaled corticosteroids in patients with respiratory disorders who develop community acquired pneumonia (CAP) is associated with a lower incidence and severity of parapneumonic effusion, according to a new study from researchers in Spain.
New research co-published by Saint Louis University and Express Scripts, Inc., suggests that men with multiple sclerosis may require more education and support to manage their disease and therapy than women with MS. Men also may benefit from more targeted adherence interventions.
Although prescription drug misuse is on the decline among adolescents, one in two patients tested between the ages of 10 and 17 years are not using their medications appropriately, potentially putting their health at risk, according to an analysis by Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services.
› Verified 7 days ago